Glycopeptide Antibacterial [EPC]

Glycopeptide Antibacterial [EPC] was reported 65558 times

Drugs of the Glycopeptide Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VANCOMYCIN INFUSION REACTION 300 0.7958
1 RED MAN SYNDROME 434 0.4932
2 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 168 0.4138
3 LINEAR IGA DISEASE 677 0.4066
4 GEOTRICHUM INFECTION 64 0.3033
5 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 82 0.2654
6 CHOROIDITIS 90 0.2406
7 TRICHOSPORON INFECTION 60 0.1481
8 RETINAL VASCULITIS 171 0.1436
9 DISSEMINATED MUCORMYCOSIS 54 0.1371
10 RHINOCEREBRAL MUCORMYCOSIS 46 0.1326
11 ENTEROCOCCUS TEST POSITIVE 78 0.1204
12 CARDIAC VALVE VEGETATION 56 0.1152
13 BACTERIAL DISEASE CARRIER 81 0.1111
14 FUNGAEMIA 174 0.1105
15 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 40 0.1053
16 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2707 0.1051
17 ACINETOBACTER INFECTION 112 0.1023
18 CONGESTIVE HEPATOPATHY 45 0.1004
19 DYSBIOSIS 81 0.0987
20 SEPTIC EMBOLUS 80 0.0962
21 SYSTEMIC CANDIDA 235 0.0935
22 STENOTROPHOMONAS INFECTION 126 0.0929
23 RENAL TUBULAR NECROSIS 898 0.0915
24 ENTEROCOCCAL INFECTION 424 0.0877
25 PSEUDOMEMBRANOUS COLITIS 190 0.0850
26 RASH MORBILLIFORM 229 0.0825
27 NEPHROPATHY TOXIC 925 0.0823
28 SEPSIS SYNDROME 41 0.0817
29 PSEUDOMONAL BACTERAEMIA 69 0.0808
30 CLOSTRIDIUM TEST POSITIVE 177 0.0802
31 FUSARIUM INFECTION 56 0.0800
32 STAPHYLOCOCCAL BACTERAEMIA 330 0.0758
33 CORYNEBACTERIUM INFECTION 39 0.0729
34 ENTEROCOCCAL SEPSIS 59 0.0728
35 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 233 0.0717
36 ENTEROCOCCAL BACTERAEMIA 75 0.0708
37 CLOSTRIDIUM DIFFICILE COLITIS 724 0.0682
38 PNEUMONIA NECROTISING 44 0.0680
39 CLOSTRIDIUM DIFFICILE INFECTION 1479 0.0677
40 MEGACOLON 105 0.0668
41 CRYSTAL NEPHROPATHY 39 0.0659
42 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 508 0.0653
43 BRONCHIAL SECRETION RETENTION 83 0.0651
44 DEVICE RELATED SEPSIS 131 0.0650
45 OTOTOXICITY 119 0.0643
46 EOSINOPHILIC PNEUMONIA ACUTE 54 0.0624
47 BACILLUS INFECTION 39 0.0617
48 SUPERINFECTION 91 0.0606
49 PATHOGEN RESISTANCE 546 0.0598
50 FUNGAL SEPSIS 49 0.0590
51 MUCORMYCOSIS 151 0.0581
52 NEPHRITIS INTERSTITIAL 73 0.0577
53 CLOSTRIDIUM COLITIS 70 0.0577
54 TOXIC ANTERIOR SEGMENT SYNDROME 62 0.0568
55 RETINAL VASCULAR OCCLUSION 42 0.0568
56 TOXIC EPIDERMAL NECROLYSIS 858 0.0564
57 APLASTIC ANAEMIA 295 0.0564
58 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 46 0.0560
59 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 59 0.0556
60 EOSINOPHILIA 952 0.0543
61 KLEBSIELLA INFECTION 273 0.0539
62 KOUNIS SYNDROME 119 0.0524
63 DIFFUSE ALVEOLAR DAMAGE 59 0.0513
64 CANDIDA SEPSIS 46 0.0513
65 ENDOCARDITIS 262 0.0510
66 ENDOCARDITIS BACTERIAL 40 0.0508
67 PROCALCITONIN INCREASED 59 0.0503
68 PNEUMONIA STAPHYLOCOCCAL 98 0.0496
69 RENAL TUBULAR INJURY 60 0.0494
70 HISTIOCYTOSIS HAEMATOPHAGIC 146 0.0491
71 CONTINUOUS HAEMODIAFILTRATION 46 0.0470
72 STAPHYLOCOCCUS TEST POSITIVE 99 0.0469
73 SYSTEMIC MYCOSIS 54 0.0462
74 TYPE IV HYPERSENSITIVITY REACTION 126 0.0460
75 MULTI-ORGAN FAILURE 789 0.0456
76 BRAIN ABSCESS 115 0.0454
77 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1282 0.0452
78 BLOOD CULTURE POSITIVE 135 0.0450
79 ENTEROBACTER INFECTION 75 0.0446
80 STAPHYLOCOCCAL SEPSIS 219 0.0443
81 ASPERGILLOSIS 57 0.0436
82 TUBULOINTERSTITIAL NEPHRITIS 813 0.0433
83 ENDOPHTHALMITIS 259 0.0431
84 HYPOPERFUSION 45 0.0428
85 MENINGITIS BACTERIAL 61 0.0426
86 BACTERAEMIA 505 0.0425
87 MULTIPLE-DRUG RESISTANCE 130 0.0419
88 SEPTIC SHOCK 1819 0.0418
89 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 158 0.0413
90 HAEMODYNAMIC INSTABILITY 314 0.0412
91 VASCULAR DEVICE INFECTION 186 0.0410
92 PNEUMONIA KLEBSIELLA 75 0.0408
93 STREPTOCOCCAL BACTERAEMIA 44 0.0404
94 STRONGYLOIDIASIS 65 0.0402
95 NEPHROGENIC ANAEMIA 185 0.0399
96 KLEBSIELLA SEPSIS 42 0.0373
97 DRUG LEVEL INCREASED 615 0.0371
98 RASH MACULO-PAPULAR 821 0.0369
99 ASPERGILLUS INFECTION 241 0.0367
100 PERIPHERAL SENSORIMOTOR NEUROPATHY 46 0.0366
101 PSEUDOMONAS INFECTION 314 0.0366
102 OLIGURIA 226 0.0364
103 CLOSTRIDIAL INFECTION 123 0.0363
104 DISSEMINATED INTRAVASCULAR COAGULATION 509 0.0361
105 BRONCHOPULMONARY ASPERGILLOSIS 280 0.0361
106 APLASIA 70 0.0357
107 INTERVERTEBRAL DISCITIS 67 0.0355
108 NEUTROPENIC COLITIS 73 0.0353
109 VENOOCCLUSIVE LIVER DISEASE 173 0.0350
110 HUMAN HERPESVIRUS 6 INFECTION 66 0.0349
111 EOSINOPHILIC PNEUMONIA 110 0.0349
112 NECROTISING COLITIS 44 0.0347
113 DRUG LEVEL ABOVE THERAPEUTIC 158 0.0345
114 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 258 0.0343
115 HYPERPARATHYROIDISM SECONDARY 85 0.0339
116 NECROTISING FASCIITIS 119 0.0337
117 PNEUMONIA FUNGAL 133 0.0337
118 BACTERIAL SEPSIS 109 0.0334
119 HISTOPLASMOSIS DISSEMINATED 52 0.0327
120 EMPYEMA 64 0.0322
121 IMMUNE THROMBOCYTOPENIA 147 0.0321
122 ACUTE KIDNEY INJURY 4911 0.0321
123 RENAL TUBULAR DISORDER 90 0.0320
124 PSEUDOMONAL SEPSIS 56 0.0319
125 DRUG CLEARANCE DECREASED 41 0.0314
126 LIVER ABSCESS 101 0.0311
127 CUTANEOUS VASCULITIS 112 0.0307
128 ACUTE RESPIRATORY DISTRESS SYNDROME 540 0.0305
129 STAPHYLOCOCCAL INFECTION 1002 0.0303
130 DIABETES INSIPIDUS 73 0.0303
131 ATELECTASIS 292 0.0302
132 DRUG RESISTANCE 771 0.0300
133 DERMATITIS EXFOLIATIVE GENERALISED 104 0.0299
134 HENOCH-SCHONLEIN PURPURA 65 0.0297
135 HAEMODIALYSIS 249 0.0296
136 FUNGAL PERITONITIS 45 0.0296
137 CRYPTOCOCCOSIS 48 0.0294
138 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 78 0.0293
139 GRAFT VERSUS HOST DISEASE 207 0.0288
140 HYPERNATRAEMIA 143 0.0287
141 ISCHAEMIC HEPATITIS 39 0.0285
142 CULTURE URINE POSITIVE 40 0.0284
143 WOUND INFECTION STAPHYLOCOCCAL 49 0.0283
144 LEUKOCYTOSIS 511 0.0282
145 HEPARIN-INDUCED THROMBOCYTOPENIA 139 0.0282
146 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 60 0.0282
147 RENAL FAILURE ACUTE 1188 0.0280
148 HYPOALBUMINAEMIA 217 0.0279
149 DERMATITIS EXFOLIATIVE 139 0.0278
150 TOXIC SKIN ERUPTION 279 0.0277
151 NOCARDIOSIS 70 0.0273
152 ADENOVIRUS INFECTION 79 0.0272
153 PULSELESS ELECTRICAL ACTIVITY 113 0.0270
154 HEPATOSPLENOMEGALY 69 0.0269
155 ESCHERICHIA BACTERAEMIA 63 0.0268
156 VENOOCCLUSIVE DISEASE 67 0.0267
157 CANDIDA INFECTION 448 0.0265
158 PNEUMOMEDIASTINUM 47 0.0260
159 DEVICE RELATED INFECTION 400 0.0260
160 GRAFT VERSUS HOST DISEASE IN SKIN 57 0.0259
161 HAEMOTHORAX 75 0.0258
162 METABOLIC ENCEPHALOPATHY 77 0.0256
163 INFECTIOUS PLEURAL EFFUSION 39 0.0256
164 STEVENS-JOHNSON SYNDROME 560 0.0252
165 NOSOCOMIAL INFECTION 55 0.0249
166 SKIN NECROSIS 129 0.0248
167 ESCHERICHIA INFECTION 204 0.0248
168 DRUG ERUPTION 437 0.0246
169 ACUTE RESPIRATORY FAILURE 463 0.0240
170 AUTOIMMUNE HAEMOLYTIC ANAEMIA 82 0.0239
171 BRAIN HERNIATION 71 0.0237
172 ENCEPHALOPATHY 582 0.0237
173 ARTHRITIS BACTERIAL 97 0.0236
174 LUNG CONSOLIDATION 66 0.0236
175 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 65 0.0235
176 DERMATITIS BULLOUS 170 0.0235
177 ANURIA 202 0.0234
178 ACIDOSIS 177 0.0231
179 TOXIC ENCEPHALOPATHY 117 0.0231
180 SHOCK 531 0.0231
181 CAPILLARY LEAK SYNDROME 47 0.0227
182 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 75 0.0227
183 HYPERSENSITIVITY VASCULITIS 59 0.0225
184 METHAEMOGLOBINAEMIA 52 0.0224
185 RENAL INJURY 664 0.0223
186 FEBRILE BONE MARROW APLASIA 94 0.0221
187 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 110 0.0221
188 JUGULAR VEIN THROMBOSIS 39 0.0219
189 DRUG LEVEL BELOW THERAPEUTIC 120 0.0217
190 RESPIRATORY FAILURE 1582 0.0217
191 LUNG INFILTRATION 191 0.0216
192 RESPIRATORY ACIDOSIS 85 0.0216
193 SEPSIS 2360 0.0211
194 CHOLESTATIC LIVER INJURY 47 0.0211
195 BACTERIAL TEST POSITIVE 47 0.0211
196 FEBRILE NEUTROPENIA 1397 0.0210
197 INTRAVENTRICULAR HAEMORRHAGE 52 0.0209
198 PROTHROMBIN TIME PROLONGED 125 0.0209
199 ABSCESS LIMB 89 0.0209
200 COMPLICATIONS OF TRANSPLANTED KIDNEY 47 0.0207
201 PULMONARY HAEMORRHAGE 161 0.0206
202 PANCYTOPENIA 1149 0.0205
203 FIBROSIS 63 0.0205
204 GLOMERULONEPHRITIS 50 0.0204
205 WOUND DEHISCENCE 68 0.0201
206 END STAGE RENAL DISEASE 365 0.0200
207 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 101 0.0199
208 HYPOXIA 700 0.0199
209 LIVEDO RETICULARIS 41 0.0196
210 CYTOMEGALOVIRUS COLITIS 45 0.0195
211 AZOTAEMIA 78 0.0195
212 DISTRIBUTIVE SHOCK 44 0.0194
213 HYPERCAPNIA 58 0.0192
214 HYPERAMMONAEMIA 96 0.0192
215 GENERALISED OEDEMA 237 0.0191
216 PURPURA 169 0.0191
217 ACUTE MYELOID LEUKAEMIA RECURRENT 41 0.0191
218 LUNG ABSCESS 40 0.0190
219 AGRANULOCYTOSIS 353 0.0190
220 CYTOLYTIC HEPATITIS 63 0.0190
221 INFLAMMATORY MARKER INCREASED 94 0.0189
222 CANDIDIASIS 76 0.0189
223 SHOCK HAEMORRHAGIC 154 0.0189
224 ORGAN FAILURE 76 0.0188
225 HYPERBILIRUBINAEMIA 195 0.0188
226 HYPOVOLAEMIA 109 0.0186
227 COAGULOPATHY 310 0.0186
228 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 110 0.0186
229 ENDOTRACHEAL INTUBATION 52 0.0185
230 MENTAL STATUS CHANGES 512 0.0184
231 CYTOMEGALOVIRUS VIRAEMIA 82 0.0184
232 MENINGITIS 123 0.0184
233 ACUTE GRAFT VERSUS HOST DISEASE 84 0.0183
234 RENAL FAILURE 2435 0.0183
235 RENAL IMPAIRMENT 1540 0.0183
236 ANHEDONIA 481 0.0183
237 EXFOLIATIVE RASH 48 0.0182
238 FEAR 487 0.0181
239 HYPERTHERMIA 138 0.0181
240 BLOOD CREATININE INCREASED 1176 0.0180
241 OSTEOMYELITIS 321 0.0177
242 IMMUNE THROMBOCYTOPENIC PURPURA 50 0.0177
243 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 41 0.0176
244 SINUS OPERATION 42 0.0176
245 NECROSIS 98 0.0176
246 STREPTOCOCCAL INFECTION 97 0.0174
247 NEUROTOXICITY 303 0.0173
248 ERYTHEMA MULTIFORME 161 0.0172
249 PNEUMONIA BACTERIAL 158 0.0172
250 RESPIRATORY DISTRESS 475 0.0172
251 CHOLESTASIS 330 0.0172
252 PERIPHERAL ISCHAEMIA 70 0.0171
253 MIXED LIVER INJURY 51 0.0169
254 NEUROLOGICAL DECOMPENSATION 39 0.0168
255 TACHYPNOEA 229 0.0168
256 CYTOMEGALOVIRUS INFECTION 278 0.0167
257 METABOLIC ACIDOSIS 533 0.0167
258 NEPHROPATHY 155 0.0166
259 REBOUND ACID HYPERSECRETION 50 0.0165
260 CYTOMEGALOVIRUS INFECTION REACTIVATION 73 0.0165
261 DIALYSIS 232 0.0163
262 AORTIC ARTERIOSCLEROSIS 42 0.0163
263 TORSADE DE POINTES 128 0.0163
264 ESCHERICHIA SEPSIS 47 0.0162
265 JAUNDICE CHOLESTATIC 57 0.0161
266 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 154 0.0161
267 PNEUMATOSIS INTESTINALIS 46 0.0161
268 CYTOKINE RELEASE SYNDROME 321 0.0160
269 RENAL FAILURE CHRONIC 123 0.0160
270 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 874 0.0159
271 ENCEPHALITIS 110 0.0159
272 THROMBOTIC THROMBOCYTOPENIC PURPURA 56 0.0159
273 BLOOD UREA INCREASED 266 0.0159
274 NEPHROGENIC SYSTEMIC FIBROSIS 48 0.0159
275 VENTRICULAR HYPOKINESIA 51 0.0159
276 NEPHRITIS 53 0.0159
277 BRAIN DEATH 49 0.0158
278 EOSINOPHIL COUNT INCREASED 132 0.0158
279 INCORRECT DRUG ADMINISTRATION RATE 67 0.0157
280 SERUM FERRITIN INCREASED 83 0.0157
281 THROMBOTIC MICROANGIOPATHY 153 0.0157
282 DRUG-INDUCED LIVER INJURY 492 0.0157
283 PULSE ABSENT 74 0.0155
284 THROMBOCYTOPENIA 1738 0.0155
285 SCOLIOSIS 96 0.0155
286 HEPATOMEGALY 151 0.0154
287 ABSCESS 245 0.0153
288 ABDOMINAL INFECTION 39 0.0153
289 URINE OUTPUT DECREASED 133 0.0152
290 LEUKOPENIA 760 0.0152
291 CYSTITIS HAEMORRHAGIC 61 0.0151
292 BLOOD ALBUMIN DECREASED 120 0.0151
293 MUCOSAL INFLAMMATION 396 0.0151
294 FACE OEDEMA 254 0.0150
295 ENTEROCOLITIS 85 0.0147
296 TRANSAMINASES INCREASED 326 0.0146
297 BLOOD BILIRUBIN INCREASED 394 0.0146
298 STATUS EPILEPTICUS 164 0.0145
299 HAEMOLYTIC ANAEMIA 129 0.0144
300 PLEURAL EFFUSION 867 0.0142
301 HYPOKALAEMIA 657 0.0142
302 MALNUTRITION 159 0.0142
303 INTESTINAL ISCHAEMIA 78 0.0142
304 NEUTROPENIC SEPSIS 101 0.0141
305 PETECHIAE 147 0.0141
306 BACTERIAL INFECTION 262 0.0140
307 BLOOD CREATINE INCREASED 62 0.0140
308 HYPERVOLAEMIA 69 0.0139
309 SINUS TACHYCARDIA 197 0.0139
310 DECUBITUS ULCER 113 0.0139
311 CACHEXIA 71 0.0138
312 HYDROCEPHALUS 75 0.0138
313 BONE MARROW FAILURE 278 0.0137
314 HEPATOCELLULAR INJURY 192 0.0135
315 PNEUMOTHORAX 214 0.0135
316 FAILURE TO THRIVE 70 0.0135
317 PULMONARY ALVEOLAR HAEMORRHAGE 75 0.0134
318 BLOOD LACTATE DEHYDROGENASE INCREASED 211 0.0133
319 HEPATIC NECROSIS 50 0.0133
320 CREATININE RENAL CLEARANCE DECREASED 53 0.0132
321 BLOOD ALKALINE PHOSPHATASE INCREASED 328 0.0132
322 TUMOUR LYSIS SYNDROME 116 0.0132
323 BRONCHOSPASM 188 0.0132
324 AORTIC VALVE INCOMPETENCE 56 0.0131
325 C-REACTIVE PROTEIN INCREASED 468 0.0128
326 PNEUMONIA VIRAL 41 0.0128
327 HYPOPHOSPHATAEMIA 94 0.0127
328 VENTRICULAR TACHYCARDIA 209 0.0126
329 EXTRAVASATION 52 0.0126
330 PURULENT DISCHARGE 54 0.0126
331 HYPERTRIGLYCERIDAEMIA 74 0.0126
332 SEROTONIN SYNDROME 242 0.0126
333 HAEMOLYSIS 97 0.0125
334 BLOOD LACTIC ACID INCREASED 66 0.0125
335 EPSTEIN-BARR VIRUS INFECTION 78 0.0125
336 CATHETER SITE INFECTION 47 0.0124
337 RASH PUSTULAR 90 0.0123
338 ASCITES 363 0.0123
339 CELLULITIS 622 0.0123
340 DRUG LEVEL DECREASED 125 0.0123
341 ABDOMINAL ABSCESS 54 0.0122
342 DEAFNESS NEUROSENSORY 40 0.0122
343 ELECTROLYTE IMBALANCE 141 0.0121
344 HEPATITIS CHOLESTATIC 73 0.0121
345 ADRENAL INSUFFICIENCY 147 0.0121
346 CARDIOGENIC SHOCK 173 0.0120
347 ANAPHYLACTIC REACTION 656 0.0119
348 GAMMA-GLUTAMYLTRANSFERASE INCREASED 263 0.0119
349 BK VIRUS INFECTION 40 0.0118
350 FLUID OVERLOAD 172 0.0118
351 HYPERTRANSAMINASAEMIA 82 0.0118
352 PYREXIA 4067 0.0117
353 ISCHAEMIA 54 0.0117
354 MYOCLONUS 140 0.0117
355 HERPES SIMPLEX 76 0.0117
356 ALANINE AMINOTRANSFERASE INCREASED 716 0.0117
357 HEPATIC FUNCTION ABNORMAL 433 0.0116
358 HYPERPYREXIA 49 0.0116
359 HYPOMAGNESAEMIA 161 0.0116
360 PNEUMOCYSTIS JIROVECII PNEUMONIA 116 0.0115
361 HYPERURICAEMIA 47 0.0114
362 MITRAL VALVE INCOMPETENCE 129 0.0114
363 HEPATIC FAILURE 342 0.0113
364 CIRCULATORY COLLAPSE 193 0.0113
365 ACUTE HEPATIC FAILURE 154 0.0113
366 ILEUS PARALYTIC 50 0.0112
367 ANAPHYLACTOID REACTION 46 0.0112
368 NEUTROPENIA 1517 0.0111
369 ANAL ABSCESS 60 0.0111
370 TRANSPLANT REJECTION 89 0.0111
371 ANGIOPATHY 62 0.0111
372 ASPARTATE AMINOTRANSFERASE INCREASED 586 0.0110
373 ARTHRITIS INFECTIVE 51 0.0110
374 FIBRIN D DIMER INCREASED 39 0.0110
375 PERITONITIS 227 0.0109
376 VENOUS THROMBOSIS 43 0.0109
377 HEPATOTOXICITY 242 0.0109
378 HYPOTENSION 2167 0.0108
379 ACUTE MYELOID LEUKAEMIA 168 0.0108
380 CARDIAC ARREST 889 0.0108
381 LEFT VENTRICULAR DYSFUNCTION 72 0.0107
382 LEFT VENTRICULAR HYPERTROPHY 46 0.0107
383 HEPATIC ENCEPHALOPATHY 100 0.0107
384 ACUTE PULMONARY OEDEMA 60 0.0107
385 CEREBRAL ISCHAEMIA 55 0.0107
386 POSTOPERATIVE WOUND INFECTION 72 0.0106
387 CYSTIC FIBROSIS 59 0.0106
388 ILEUS 132 0.0106
389 UNRESPONSIVE TO STIMULI 272 0.0105
390 RETINAL HAEMORRHAGE 75 0.0105
391 THERAPY NON-RESPONDER 473 0.0105
392 ORGANISING PNEUMONIA 52 0.0105
393 TACHYCARDIA 931 0.0105
394 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 57 0.0105
395 MENINGITIS ASEPTIC 47 0.0105
396 BUNDLE BRANCH BLOCK RIGHT 48 0.0104
397 RASH ERYTHEMATOUS 497 0.0104
398 TREATMENT FAILURE 857 0.0103
399 INJURY 726 0.0103
400 CHOLANGITIS 64 0.0103
401 VENTRICULAR FIBRILLATION 114 0.0103
402 CARDIOMEGALY 126 0.0102
403 LARGE INTESTINE PERFORATION 71 0.0102
404 PERIORBITAL OEDEMA 53 0.0102
405 HYPERKALAEMIA 356 0.0101
406 TRICUSPID VALVE INCOMPETENCE 80 0.0101
407 BRAIN OEDEMA 127 0.0100
408 ELECTROCARDIOGRAM QT PROLONGED 354 0.0098
409 SUBCUTANEOUS ABSCESS 47 0.0098
410 VASCULITIS 114 0.0098
411 ANAPHYLACTIC SHOCK 251 0.0097
412 JOINT EFFUSION 67 0.0097
413 POST PROCEDURAL INFECTION 79 0.0097
414 HEPATIC CYTOLYSIS 123 0.0096
415 LACTIC ACIDOSIS 312 0.0096
416 NEUROLOGICAL SYMPTOM 55 0.0096
417 HYPOVOLAEMIC SHOCK 46 0.0096
418 LOW BIRTH WEIGHT BABY 76 0.0096
419 COLITIS 362 0.0095
420 WHITE BLOOD CELL COUNT INCREASED 366 0.0095
421 RASH GENERALISED 247 0.0095
422 FUNGAL INFECTION 316 0.0095
423 RALES 55 0.0095
424 HEPATITIS 242 0.0094
425 GLOMERULAR FILTRATION RATE DECREASED 116 0.0094
426 CARDIAC MURMUR 81 0.0094
427 LIVER INJURY 229 0.0093
428 PERITONITIS BACTERIAL 93 0.0092
429 UROSEPSIS 85 0.0092
430 ECCHYMOSIS 63 0.0092
431 CARDIO-RESPIRATORY ARREST 383 0.0091
432 COVID-19 PNEUMONIA 108 0.0091
433 WOUND INFECTION 100 0.0091
434 RESPIRATORY RATE INCREASED 81 0.0091
435 RASH VESICULAR 44 0.0091
436 LYMPHOPENIA 128 0.0090
437 FOETAL GROWTH RESTRICTION 55 0.0090
438 ATRIAL FLUTTER 72 0.0090
439 HEPATIC LESION 39 0.0090
440 GENERALISED ERYTHEMA 51 0.0090
441 SPLENOMEGALY 105 0.0090
442 BREATH SOUNDS ABNORMAL 44 0.0089
443 SUSPECTED OFF LABEL USE 40 0.0088
444 MYOPATHY 76 0.0088
445 CHRONIC KIDNEY DISEASE 667 0.0088
446 INTERNATIONAL NORMALISED RATIO INCREASED 250 0.0088
447 NONSPECIFIC REACTION 48 0.0087
448 COLITIS ISCHAEMIC 59 0.0087
449 PULMONARY OEDEMA 391 0.0087
450 CHOLECYSTITIS 104 0.0087
451 BLOOD CREATINE PHOSPHOKINASE INCREASED 251 0.0087
452 TROPONIN INCREASED 66 0.0087
453 PAPULE 61 0.0087
454 PERICARDIAL EFFUSION 200 0.0086
455 GANGRENE 52 0.0086
456 DRUG INTERACTION 1367 0.0086
457 APNOEA 67 0.0086
458 VENTRICULAR EXTRASYSTOLES 89 0.0086
459 SUPRAVENTRICULAR TACHYCARDIA 82 0.0086
460 LIPASE INCREASED 65 0.0085
461 CHOLECYSTITIS ACUTE 48 0.0085
462 LOCALISED OEDEMA 39 0.0084
463 GRANULOCYTOPENIA 48 0.0084
464 PLEURISY 50 0.0084
465 IMMUNOSUPPRESSION 74 0.0084
466 ODYNOPHAGIA 50 0.0084
467 ALTERED STATE OF CONSCIOUSNESS 181 0.0083
468 INFUSION SITE EXTRAVASATION 52 0.0083
469 HAEMATOCRIT DECREASED 165 0.0083
470 RHABDOMYOLYSIS 346 0.0083
471 ORAL CANDIDIASIS 109 0.0083
472 NEUTROPHILIA 47 0.0083
473 ABDOMINAL TENDERNESS 41 0.0082
474 SUBARACHNOID HAEMORRHAGE 84 0.0082
475 PROCTALGIA 53 0.0082
476 PNEUMONITIS 224 0.0082
477 JAUNDICE 221 0.0082
478 CARDIAC TAMPONADE 39 0.0082
479 HYPOTHERMIA 83 0.0082
480 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 42 0.0082
481 BODY TEMPERATURE INCREASED 167 0.0082
482 SINUS BRADYCARDIA 79 0.0082
483 UNEVALUABLE EVENT 618 0.0082
484 REFUSAL OF TREATMENT BY PATIENT 53 0.0081
485 PULMONARY HYPERTENSION 168 0.0081
486 RENAL CYST 64 0.0081
487 MOUTH HAEMORRHAGE 59 0.0080
488 HAEMORRHAGE INTRACRANIAL 120 0.0080
489 HYDRONEPHROSIS 60 0.0080
490 PERIPHERAL VASCULAR DISORDER 41 0.0080
491 HYPOCALCAEMIA 150 0.0079
492 HAEMOPTYSIS 221 0.0079
493 HYPOGAMMAGLOBULINAEMIA 52 0.0079
494 DIVERTICULUM 56 0.0079
495 LYMPHADENOPATHY 278 0.0078
496 PLATELET COUNT DECREASED 837 0.0078
497 CARDIOMYOPATHY 116 0.0078
498 CYTOPENIA 96 0.0078
499 FISTULA 88 0.0078
500 SPINAL OSTEOARTHRITIS 68 0.0077
501 EMPHYSEMA 78 0.0077
502 NEUTROPHIL COUNT DECREASED 315 0.0077
503 CARDIAC VALVE DISEASE 44 0.0077
504 HEPATITIS ACUTE 50 0.0077
505 ECONOMIC PROBLEM 116 0.0076
506 PNEUMONIA ASPIRATION 191 0.0076
507 TRANSFUSION 80 0.0076
508 DELIRIUM 264 0.0076
509 UPPER GASTROINTESTINAL HAEMORRHAGE 127 0.0075
510 SKIN LESION 207 0.0075
511 NO THERAPEUTIC RESPONSE 92 0.0075
512 UVEITIS 102 0.0075
513 OESOPHAGITIS 82 0.0075
514 ORAL DISORDER 55 0.0075
515 GENERALISED TONIC-CLONIC SEIZURE 124 0.0075
516 COMPRESSION FRACTURE 40 0.0075
517 HYPONATRAEMIA 420 0.0074
518 POST PROCEDURAL COMPLICATION 143 0.0074
519 CONDITION AGGRAVATED 2220 0.0073
520 RIGHT VENTRICULAR FAILURE 51 0.0073
521 INTRACRANIAL PRESSURE INCREASED 40 0.0072
522 MELAENA 157 0.0071
523 SKIN PLAQUE 60 0.0071
524 PROTEINURIA 135 0.0071
525 ANAEMIA 1353 0.0071
526 CYANOSIS 111 0.0071
527 RIB FRACTURE 145 0.0070
528 ATRIAL FIBRILLATION 686 0.0070
529 HYPERCALCAEMIA 86 0.0070
530 POLYURIA 57 0.0070
531 WRONG PRODUCT ADMINISTERED 47 0.0069
532 CARDIAC FAILURE ACUTE 46 0.0069
533 BRADYCARDIA 366 0.0069
534 STRESS CARDIOMYOPATHY 40 0.0069
535 BLOOD CALCIUM DECREASED 77 0.0068
536 DIARRHOEA HAEMORRHAGIC 64 0.0068
537 PNEUMONIA 2210 0.0068
538 LUNG INFECTION 106 0.0068
539 TENDERNESS 71 0.0068
540 NERVOUS SYSTEM DISORDER 212 0.0068
541 LIVER FUNCTION TEST ABNORMAL 197 0.0068
542 ACUTE MYOCARDIAL INFARCTION 199 0.0067
543 GASTROINTESTINAL HAEMORRHAGE 564 0.0067
544 HAEMATURIA 229 0.0067
545 DRUG TOXICITY 91 0.0067
546 PANCREATITIS ACUTE 150 0.0067
547 PLATELET COUNT INCREASED 87 0.0067
548 DUODENAL ULCER 47 0.0067
549 NEUTROPHIL COUNT INCREASED 68 0.0066
550 MYOCARDITIS 76 0.0066
551 CEREBRAL INFARCTION 162 0.0066
552 EJECTION FRACTION DECREASED 103 0.0066
553 DIFFUSE LARGE B-CELL LYMPHOMA 51 0.0066
554 OEDEMA 357 0.0066
555 MYOSITIS 59 0.0066
556 OXYGEN SATURATION DECREASED 369 0.0066
557 DEPRESSED LEVEL OF CONSCIOUSNESS 258 0.0065
558 GASTROENTERITIS 95 0.0065
559 ARTERIOSCLEROSIS 61 0.0065
560 INFECTION 934 0.0064
561 RESPIRATORY SYNCYTIAL VIRUS INFECTION 56 0.0064
562 INTESTINAL PERFORATION 72 0.0064
563 ENTERITIS 41 0.0064
564 EMBOLISM 53 0.0064
565 HAEMATOMA 165 0.0064
566 PULMONARY TOXICITY 45 0.0064
567 SMALL INTESTINAL OBSTRUCTION 78 0.0063
568 LYMPHOCYTE COUNT DECREASED 112 0.0063
569 PREMATURE BABY 190 0.0063
570 NERVE COMPRESSION 58 0.0063
571 INTRAOCULAR PRESSURE INCREASED 80 0.0063
572 GENERAL PHYSICAL HEALTH DETERIORATION 724 0.0063
573 PYELONEPHRITIS 54 0.0062
574 ASPIRATION 68 0.0062
575 INFUSION RELATED REACTION 409 0.0062
576 LIVER DISORDER 272 0.0061
577 DISEASE PROGRESSION 725 0.0061
578 ELECTROCARDIOGRAM ABNORMAL 48 0.0061
579 HAEMOGLOBIN DECREASED 622 0.0061
580 BLOOD POTASSIUM DECREASED 182 0.0060
581 PULMONARY CONGESTION 79 0.0060
582 PREMATURE DELIVERY 95 0.0060
583 RASH PRURITIC 323 0.0060
584 BLOOD SODIUM DECREASED 112 0.0059
585 POLYNEUROPATHY 71 0.0059
586 BLISTER 333 0.0059
587 WHITE BLOOD CELL COUNT DECREASED 636 0.0059
588 POST PROCEDURAL HAEMORRHAGE 68 0.0058
589 MOUTH ULCERATION 123 0.0058
590 RESPIRATORY DEPRESSION 71 0.0058
591 BLOOD POTASSIUM INCREASED 94 0.0058
592 HYPOPHAGIA 148 0.0058
593 ATAXIA 68 0.0057
594 HYPOTONIA 57 0.0057
595 DEEP VEIN THROMBOSIS 371 0.0057
596 BLOOD PRESSURE DIASTOLIC DECREASED 42 0.0057
597 BLOOD MAGNESIUM DECREASED 49 0.0057
598 COMA 270 0.0057
599 DRUG INEFFECTIVE 7429 0.0056
600 INTERVERTEBRAL DISC DEGENERATION 52 0.0056
601 HYPERLIPIDAEMIA 67 0.0056
602 OSTEOPENIA 85 0.0056
603 CHILLS 656 0.0056
604 SKIN ULCER 144 0.0056
605 NEUROLEPTIC MALIGNANT SYNDROME 66 0.0056
606 PSYCHIATRIC SYMPTOM 41 0.0055
607 LOWER GASTROINTESTINAL HAEMORRHAGE 41 0.0055
608 PALLOR 150 0.0055
609 PULMONARY MASS 82 0.0055
610 LIVER FUNCTION TEST INCREASED 118 0.0055
611 RENAL DISORDER 256 0.0055
612 INFUSION SITE ERYTHEMA 46 0.0055
613 EYE INFLAMMATION 52 0.0054
614 OFF LABEL USE 4760 0.0054
615 LETHARGY 311 0.0054
616 BRAIN INJURY 54 0.0054
617 PROCEDURAL COMPLICATION 41 0.0053
618 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 47 0.0053
619 DERMATITIS 111 0.0053
620 ANGIOEDEMA 234 0.0053
621 BLOOD PRESSURE DECREASED 351 0.0053
622 CARDIAC FAILURE 423 0.0053
623 APPENDICITIS 49 0.0052
624 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 89 0.0052
625 CEREBRAL HAEMORRHAGE 187 0.0052
626 HYPERGLYCAEMIA 190 0.0052
627 OBSTRUCTIVE AIRWAYS DISORDER 58 0.0052
628 RASH MACULAR 182 0.0052
629 GRAND MAL CONVULSION 48 0.0052
630 EYELID OEDEMA 60 0.0052
631 CARDIOTOXICITY 46 0.0052
632 DISEASE RECURRENCE 244 0.0051
633 ABNORMAL FAECES 42 0.0051
634 ERYTHEMA 1041 0.0051
635 HAEMATEMESIS 128 0.0050
636 TOXICITY TO VARIOUS AGENTS 850 0.0050
637 RASH 2186 0.0050
638 DISORIENTATION 197 0.0050
639 EMOTIONAL DISTRESS 601 0.0050
640 SPUTUM DISCOLOURED 47 0.0050
641 RESPIRATORY DISORDER 148 0.0049
642 FLANK PAIN 46 0.0049
643 OEDEMA PERIPHERAL 598 0.0049
644 VISUAL ACUITY REDUCED 162 0.0049
645 HAEMATOCHEZIA 267 0.0048
646 INTERSTITIAL LUNG DISEASE 234 0.0048
647 DEAFNESS 125 0.0048
648 WEIGHT FLUCTUATION 50 0.0048
649 SKIN HYPERPIGMENTATION 41 0.0048
650 DERMATITIS ALLERGIC 60 0.0048
651 HEPATIC ENZYME INCREASED 323 0.0047
652 HALLUCINATION, VISUAL 100 0.0047
653 LEUKAEMIA 44 0.0047
654 ORAL HERPES 91 0.0047
655 PRODUCT USE IN UNAPPROVED INDICATION 1154 0.0047
656 WHEEZING 276 0.0046
657 INCONTINENCE 49 0.0046
658 HAEMORRHOIDS 90 0.0046
659 SUBDURAL HAEMATOMA 66 0.0046
660 CHOLELITHIASIS 151 0.0046
661 PRODUCT ADMINISTRATION ERROR 93 0.0046
662 INTERVERTEBRAL DISC PROTRUSION 100 0.0046
663 HYPOKINESIA 66 0.0045
664 PERICARDITIS 76 0.0045
665 DEFORMITY 42 0.0045
666 HEPATIC STEATOSIS 83 0.0045
667 EPILEPSY 135 0.0044
668 LOCALISED INFECTION 106 0.0044
669 INFLAMMATION 226 0.0044
670 GASTRITIS 115 0.0044
671 URINARY TRACT INFECTION 744 0.0044
672 RED BLOOD CELL SEDIMENTATION RATE INCREASED 48 0.0043
673 MYOCARDIAL ISCHAEMIA 49 0.0043
674 APHASIA 130 0.0043
675 ABDOMINAL PAIN 1001 0.0043
676 DEHYDRATION 573 0.0043
677 COLITIS ULCERATIVE 192 0.0043
678 IMPAIRED HEALING 141 0.0043
679 HYPOGLYCAEMIA 208 0.0043
680 RED BLOOD CELL COUNT DECREASED 122 0.0043
681 SKIN REACTION 60 0.0043
682 HEMIPARESIS 72 0.0042
683 JOINT RANGE OF MOTION DECREASED 57 0.0042
684 MYELOSUPPRESSION 153 0.0042
685 HIATUS HERNIA 55 0.0042
686 RESPIRATORY ARREST 117 0.0042
687 EXPOSURE DURING PREGNANCY 263 0.0042
688 FREQUENT BOWEL MOVEMENTS 114 0.0042
689 RASH PAPULAR 94 0.0042
690 PHARYNGITIS 52 0.0042
691 PULMONARY EMBOLISM 397 0.0042
692 SKIN EXFOLIATION 352 0.0042
693 IMMUNODEFICIENCY 62 0.0042
694 CONFUSIONAL STATE 672 0.0042
695 ULCER 66 0.0041
696 MUSCULOSKELETAL CHEST PAIN 64 0.0041
697 HYPERTENSIVE CRISIS 46 0.0041
698 VITAMIN D DEFICIENCY 40 0.0041
699 RECTAL HAEMORRHAGE 176 0.0041
700 PRODUCT PRESCRIBING ISSUE 89 0.0041
701 MASS 57 0.0041
702 URTICARIA 683 0.0041
703 LYMPHOMA 63 0.0041
704 THERAPY PARTIAL RESPONDER 63 0.0040
705 SCAR 69 0.0040
706 LIP SWELLING 134 0.0040
707 STOMATITIS 244 0.0040
708 CARDIAC FAILURE CONGESTIVE 323 0.0040
709 REBOUND EFFECT 45 0.0040
710 HEART RATE INCREASED 393 0.0040
711 RESPIRATORY TRACT CONGESTION 63 0.0040
712 LUNG DISORDER 194 0.0040
713 INFUSION SITE PAIN 51 0.0040
714 PAIN IN JAW 112 0.0039
715 ANXIETY 1123 0.0039
716 WOUND 110 0.0039
717 MUSCLE RIGIDITY 47 0.0039
718 SKIN INFECTION 44 0.0039
719 DYSPHAGIA 371 0.0039
720 CHROMATURIA 88 0.0039
721 IMPAIRED QUALITY OF LIFE 56 0.0039
722 INJECTION SITE EXTRAVASATION 48 0.0039
723 POOR VENOUS ACCESS 40 0.0039
724 VIRAL INFECTION 128 0.0038
725 CONVULSION 219 0.0038
726 DIVERTICULITIS 106 0.0038
727 PANCREATITIS 202 0.0038
728 EPISTAXIS 280 0.0037
729 AGITATION 272 0.0037
730 ARRHYTHMIA 175 0.0037
731 DIARRHOEA 2373 0.0037
732 DYSARTHRIA 138 0.0037
733 HYPERSENSITIVITY 679 0.0037
734 OSTEONECROSIS OF JAW 90 0.0036
735 GLAUCOMA 70 0.0036
736 PRODUCTIVE COUGH 173 0.0036
737 TREATMENT NONCOMPLIANCE 198 0.0036
738 NEUROPATHY PERIPHERAL 340 0.0036
739 BONE DISORDER 65 0.0036
740 HEPATIC CIRRHOSIS 67 0.0036
741 TOOTH INFECTION 47 0.0036
742 MYELODYSPLASTIC SYNDROME 51 0.0035
743 DENTAL CARIES 39 0.0035
744 GASTRIC ULCER 67 0.0035
745 MATERNAL EXPOSURE DURING PREGNANCY 312 0.0035
746 RESPIRATORY TRACT INFECTION 91 0.0035
747 SEIZURE 401 0.0035
748 LOWER RESPIRATORY TRACT INFECTION 157 0.0034
749 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 244 0.0034
750 PRURITUS 1318 0.0034
751 HERPES ZOSTER 197 0.0034
752 CONJUNCTIVITIS 63 0.0034
753 PULMONARY FIBROSIS 65 0.0034
754 SKIN DISORDER 111 0.0033
755 UPPER RESPIRATORY TRACT INFECTION 152 0.0033
756 PARALYSIS 47 0.0033
757 BLOOD PRESSURE SYSTOLIC INCREASED 64 0.0033
758 EYE PAIN 185 0.0033
759 DYSPNOEA 1846 0.0033
760 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 170 0.0033
761 OSTEOARTHRITIS 138 0.0033
762 HAEMORRHAGE 339 0.0032
763 OSTEOPOROSIS 133 0.0032
764 TENDONITIS 50 0.0032
765 FAECES DISCOLOURED 70 0.0032
766 ABDOMINAL DISTENSION 337 0.0032
767 URINARY RETENTION 107 0.0032
768 SWELLING FACE 208 0.0032
769 ISCHAEMIC STROKE 57 0.0032
770 SINUS DISORDER 63 0.0032
771 ADVERSE REACTION 42 0.0032
772 BLINDNESS 129 0.0032
773 FOETAL EXPOSURE DURING PREGNANCY 257 0.0032
774 DYSPNOEA EXERTIONAL 119 0.0032
775 PHOTOPHOBIA 59 0.0031
776 TOOTH LOSS 65 0.0031
777 HYPERTENSION 662 0.0031
778 PRURITUS GENERALISED 67 0.0031
779 VOMITING 1455 0.0031
780 LABORATORY TEST ABNORMAL 91 0.0031
781 ORAL PAIN 69 0.0031
782 CORONARY ARTERY DISEASE 93 0.0031
783 LOCAL SWELLING 53 0.0030
784 METASTASES TO LIVER 53 0.0030
785 KIDNEY INFECTION 59 0.0030
786 ANGINA PECTORIS 86 0.0030
787 INTENTIONAL PRODUCT USE ISSUE 261 0.0030
788 HEART RATE IRREGULAR 67 0.0030
789 HYPOTHYROIDISM 92 0.0029
790 METASTASES TO BONE 47 0.0029
791 MUSCLE TWITCHING 66 0.0029
792 FLUSHING 288 0.0028
793 HEART RATE DECREASED 99 0.0028
794 NEPHROLITHIASIS 129 0.0028
795 RESTLESSNESS 102 0.0028
796 BLOOD TRIGLYCERIDES INCREASED 49 0.0028
797 HYPOACUSIS 119 0.0028
798 MENTAL IMPAIRMENT 67 0.0028
799 ORTHOSTATIC HYPOTENSION 48 0.0028
800 GASTROOESOPHAGEAL REFLUX DISEASE 221 0.0027
801 GOUT 49 0.0027
802 DISABILITY 54 0.0027
803 SWOLLEN TONGUE 85 0.0027
804 BLOOD PRESSURE INCREASED 414 0.0027
805 CHEST PAIN 500 0.0027
806 DRUG INTOLERANCE 260 0.0027
807 SYNCOPE 265 0.0026
808 COUGH 740 0.0026
809 DYSURIA 97 0.0026
810 EAR INFECTION 70 0.0026
811 PAIN 1602 0.0026
812 ASTHENIA 980 0.0026
813 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 125 0.0026
814 GASTROINTESTINAL DISORDER 233 0.0026
815 URINARY INCONTINENCE 77 0.0026
816 ACCIDENTAL OVERDOSE 95 0.0026
817 BONE LOSS 39 0.0026
818 THERAPEUTIC RESPONSE DECREASED 157 0.0026
819 CYSTITIS 82 0.0026
820 SINUSITIS 263 0.0026
821 HALLUCINATION 193 0.0026
822 WEIGHT DECREASED 701 0.0025
823 MEDICATION ERROR 139 0.0025
824 PLASMA CELL MYELOMA 97 0.0025
825 THROAT TIGHTNESS 67 0.0025
826 INTESTINAL OBSTRUCTION 93 0.0025
827 INCREASED APPETITE 47 0.0025
828 BLOOD PRESSURE FLUCTUATION 59 0.0025
829 TOOTHACHE 44 0.0024
830 PRESCRIBED OVERDOSE 47 0.0024
831 LOSS OF CONSCIOUSNESS 309 0.0024
832 NEURALGIA 58 0.0024
833 TYPE 2 DIABETES MELLITUS 80 0.0024
834 PRODUCT USE ISSUE 446 0.0024
835 SWELLING 222 0.0024
836 AGGRESSION 118 0.0024
837 BACK PAIN 546 0.0023
838 BRONCHITIS 173 0.0023
839 SKIN DISCOLOURATION 107 0.0023
840 SLEEP APNOEA SYNDROME 44 0.0023
841 MALIGNANT NEOPLASM PROGRESSION 236 0.0023
842 INFLUENZA 257 0.0023
843 DECREASED APPETITE 533 0.0023
844 DEPRESSION 522 0.0023
845 COVID-19 401 0.0023
846 TREMOR 378 0.0023
847 HYPERHIDROSIS 292 0.0023
848 EAR PAIN 44 0.0023
849 UPPER LIMB FRACTURE 45 0.0023
850 RETCHING 48 0.0022
851 OROPHARYNGEAL PAIN 208 0.0022
852 GALLBLADDER DISORDER 40 0.0022
853 NAUSEA 1770 0.0022
854 ILLNESS 230 0.0022
855 OSTEONECROSIS 73 0.0022
856 SEDATION 58 0.0022
857 DIABETES MELLITUS INADEQUATE CONTROL 39 0.0022
858 TINNITUS 101 0.0022
859 LIMB DISCOMFORT 68 0.0022
860 FLATULENCE 124 0.0022
861 ASTHMA 245 0.0022
862 FEELING HOT 132 0.0022
863 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 49 0.0021
864 BONE DENSITY DECREASED 65 0.0021
865 FEEDING DISORDER 42 0.0021
866 PRODUCT DISPENSING ERROR 45 0.0021
867 SOMNOLENCE 416 0.0021
868 ECZEMA 108 0.0021
869 DIABETES MELLITUS 157 0.0021
870 FOOT FRACTURE 39 0.0021
871 THROMBOSIS 163 0.0020
872 PALPITATIONS 236 0.0020
873 BLOOD PRESSURE ABNORMAL 40 0.0020
874 SYSTEMIC LUPUS ERYTHEMATOSUS 71 0.0020
875 SPEECH DISORDER 104 0.0020
876 JOINT STIFFNESS 52 0.0020
877 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 58 0.0020
878 NASAL CONGESTION 116 0.0020
879 FLUID RETENTION 100 0.0020
880 DIABETIC KETOACIDOSIS 47 0.0020
881 CEREBROVASCULAR ACCIDENT 328 0.0019
882 MUSCULAR WEAKNESS 219 0.0019
883 BURNING SENSATION 135 0.0019
884 NECK PAIN 106 0.0019
885 NIGHT SWEATS 61 0.0019
886 PRESYNCOPE 46 0.0019
887 MUSCULOSKELETAL PAIN 99 0.0019
888 CHEST DISCOMFORT 191 0.0019
889 DRUG ADMINISTRATION ERROR 57 0.0019
890 RHINORRHOEA 120 0.0019
891 PERIPHERAL SWELLING 285 0.0018
892 ADVERSE DRUG REACTION 164 0.0018
893 MYALGIA 306 0.0018
894 CONTUSION 172 0.0018
895 DISCOMFORT 109 0.0018
896 DYSKINESIA 72 0.0018
897 PROCEDURAL PAIN 49 0.0018
898 MALAISE 769 0.0018
899 DEMENTIA 49 0.0018
900 MYOCARDIAL INFARCTION 303 0.0017
901 ABDOMINAL PAIN LOWER 43 0.0017
902 ABASIA 42 0.0017
903 WEIGHT INCREASED 377 0.0017
904 NEOPLASM PROGRESSION 58 0.0017
905 LIMB INJURY 45 0.0017
906 DEATH 1399 0.0016
907 CONSTIPATION 353 0.0016
908 FALL 538 0.0016
909 AMNESIA 105 0.0016
910 JOINT SWELLING 194 0.0016
911 PARAESTHESIA 251 0.0016
912 PAIN IN EXTREMITY 468 0.0016
913 BONE PAIN 93 0.0016
914 OCULAR HYPERAEMIA 75 0.0016
915 DYSSTASIA 46 0.0016
916 DYSPHONIA 92 0.0016
917 MENTAL DISORDER 68 0.0016
918 ABDOMINAL PAIN UPPER 317 0.0015
919 THERAPY CESSATION 78 0.0015
920 ARTHRITIS 119 0.0015
921 GAIT DISTURBANCE 289 0.0015
922 EYE SWELLING 56 0.0015
923 MOBILITY DECREASED 108 0.0015
924 TRANSIENT ISCHAEMIC ATTACK 50 0.0015
925 VERTIGO 90 0.0015
926 CARDIAC DISORDER 138 0.0015
927 HYPOAESTHESIA 216 0.0014
928 OVERDOSE 310 0.0014
929 VISUAL IMPAIRMENT 178 0.0014
930 COGNITIVE DISORDER 67 0.0014
931 HIP FRACTURE 45 0.0014
932 FATIGUE 1059 0.0014
933 HEAD INJURY 43 0.0014
934 EYE DISORDER 44 0.0013
935 IRRITABILITY 80 0.0013
936 HOSPITALISATION 204 0.0013
937 CATARACT 79 0.0013
938 ARTHRALGIA 549 0.0013
939 POLLAKIURIA 55 0.0013
940 NASOPHARYNGITIS 241 0.0013
941 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 234 0.0013
942 HEADACHE 809 0.0013
943 CONTRAINDICATED PRODUCT ADMINISTERED 39 0.0013
944 THROAT IRRITATION 57 0.0013
945 DISTURBANCE IN ATTENTION 68 0.0013
946 DYSPEPSIA 124 0.0013
947 INCORRECT ROUTE OF DRUG ADMINISTRATION 44 0.0012
948 NERVOUSNESS 64 0.0012
949 ILL-DEFINED DISORDER 74 0.0012
950 DIZZINESS 603 0.0012
951 MUSCULOSKELETAL STIFFNESS 105 0.0012
952 BALANCE DISORDER 103 0.0012
953 BLOOD GLUCOSE DECREASED 57 0.0012
954 DRY EYE 59 0.0012
955 ABDOMINAL DISCOMFORT 198 0.0012
956 SURGERY 69 0.0012
957 ABNORMAL BEHAVIOUR 46 0.0012
958 NO ADVERSE EVENT 209 0.0012
959 ROAD TRAFFIC ACCIDENT 48 0.0011
960 INFLUENZA LIKE ILLNESS 92 0.0011
961 MIGRAINE 105 0.0011
962 VISION BLURRED 148 0.0011
963 INSOMNIA 285 0.0011
964 SLEEP DISORDER 75 0.0011
965 DYSGEUSIA 77 0.0010
966 INTENTIONAL PRODUCT MISUSE 90 0.0010
967 BLOOD GLUCOSE INCREASED 192 0.0010
968 ARTHROPATHY 54 0.0010
969 MUSCLE SPASMS 178 0.0010
970 INCORRECT DOSE ADMINISTERED 220 0.0010
971 RHEUMATOID ARTHRITIS 105 0.0009
972 DRY MOUTH 73 0.0009
973 DRUG EFFECT DECREASED 45 0.0008
974 DRUG WITHDRAWAL SYNDROME 73 0.0008
975 FEELING ABNORMAL 199 0.0008
976 ALOPECIA 162 0.0008
977 ADVERSE EVENT 76 0.0008
978 THERAPY INTERRUPTED 57 0.0008
979 NEOPLASM MALIGNANT 53 0.0008
980 MEMORY IMPAIRMENT 109 0.0008
981 SUICIDAL IDEATION 69 0.0008
982 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 46 0.0006
983 HOT FLUSH 48 0.0006
984 DRY SKIN 84 0.0006
985 PRODUCT DOSE OMISSION ISSUE 183 0.0006
986 PRODUCT QUALITY ISSUE 83 0.0006
987 DEVICE MALFUNCTION 41 0.0006
988 PRODUCT STORAGE ERROR 51 0.0006
989 UNDERDOSE 42 0.0006
990 PSORIASIS 60 0.0005
991 INJECTION SITE ERYTHEMA 48 0.0004
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 74 0.0004
993 DRUG DOSE OMISSION 52 0.0003
994 INJECTION SITE PAIN 78 0.0003